November
Medicinal Chemistry
Strategy Meeting East Coast USA 2024
Reinvigorating Productivity in Pharmarn Biotech Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
Le Meridien Cambridge Bostondays
hours
minutes
seconds
What makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our 2024 Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.
Alex Nivorozhkin
Chief Scientific Officer Cybin
Andrew Zhang
Director, Head of Chemical Biology AstraZeneca
Benoit Moreau
Head of Medicinal Chemistry Remix Therapeutics
Blaise Lippa
SVP, Molecular Discovery Morphic Therapeutics
Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University
Ed Olhava
Senior Vice President, Preclinical Development IFM Therapeutics
G. Joseph Franklin
Senior Vice President and Head of Early Discovery Anagenex
Jeremy Edmunds
Executive Director Immunology Chemistry AbbVie
Ken Lind
Senior Director, Head of Chemical Computing Sciences Jnana Therapeutics
Kenneth Duncan
VP, Chemistry Accent Therapeutics
Mark Ledeboer
SVP Drug Discovery Expansion Therapeutics
Monica Schenone
Head of Chemical Biology Pfizer
Richard Heidebrecht
Vice President and R&D Glycologix
Robert Goodnow
Head Drug Discovery Sciences Takeda
Shankar Venkatraman
Executive Director, Chemistry IFM Therapeutics2024 AGENDA
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Looking into the Pivotal Role of AI in Drug Discovery
-Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center
Boston University
Innovative and Emerging Modalities
Challenges and solutions in the hit-tolead phase: ensuring efficacy and safety in drug development
-Benoit Moreau
Head of Medicinal Chemistry
Remix Therapeutics
Chemical Biology, Targeted Protein Degradation & Undruggables
Pioneering Chemical and Proteomics Approaches: Unraveling Efficacy and Safety in Small Molecule and Protein Degradation Across Multiple Therapeutic Frontiers
-Andrew Zhang
Director, Head of Chemical Biology
AstraZeneca
Hit Identification / Lead Optimization
From Hits to Leads: Advanced Strategies and Technologies for Enhancing Drug Discovery in the Initial Phases
-Richard Heidebrecht
Vice President and R&D
Glycologix
Design & Synthesis
Streamlining the hit-to-candidate process: Strategies to most effectively advance chemical matter from hit to clinical candidate
-Shankar Venkatraman
Executive Director, Chemistry
IFM Therapeutics
Integrated Drug Discovery
Addressing the Unmet Needs in CNS Drug Discovery: New Paradigms in Target Identification and Drug Development
-Alex Nivorozhkin
Chief Scientific Officer
Cybin
Roundtable Tracks
2Leveraging Generative Modeling to Accelerate Drug Discovery
Sponsor
Innovative and Emerging ModalitiesExamining the Mechanism and Effects of Induced Proximity Modalities
Sponsor
Chemical Biology, Targeted Protein Degradation & UndruggablesMethods of Computation and Cheminformatics for Chemical Synthesis and Hit Finding for Tough Targets and New Therapeutic Approaches
WuXi AppTec
Hit Identification / Lead OptimizationInnovative Approaches to Lead Optimization: Integrating Computational Methods and Machine Learning in Small Molecule Design
Sponsor
Design & SynthesisExploiting the Selectivity and Efficiency of Enzymes in Complex Molecule Synthesis
Sponsor
Integrated Drug DiscoveryThe Convergence of AI and Drug Discovery: Innovative Approaches to Accelerating the Development Pipeline
Sponsor
Roundtable Tracks
3The Evolution of AI: Looking Back at the Past 10 years and Projecting the Future 10
Innovative and Emerging Modalities
Beyond Small Molecules: The Rise of Biologics and Biosimilars in Modern Therapeutics
-Robert Goodnow
Head Drug Discovery Sciences
Takeda
Chemical Biology, Targeted Protein Degradation & Undruggables
Exploring the Current Formulation Challenges in Undruggable Leads
-Ed Olhava
Senior Vice President, Preclinical Development
IFM Therapeutics
Hit Identification / Lead Optimization
The Evolution of Hit-to-Lead Paradigms: Combining Traditional Approaches with Modern Innovations in Small Molecule Research
-G. Joseph Franklin
Senior Vice President and Head of Early Discovery
Anagenex
Design & Synthesis
The Best Methods for Synthesizing Quantities Ranging From Milligrams To Kilograms
-Kenneth Duncan
VP, Chemistry
Accent Therapeutics
Integrated Drug Discovery
What Are the Key Challenges in Integrating RNA-Based Therapies into the Drug Discovery Pipeline?
-Mark Ledeboer
SVP Drug Discovery
Expansion Therapeutics
Formulation Development Strategies for Poorly Soluble Compounds
Roundtable Tracks
4Revolutionizing Drug Discovery: Unleashing AI and Generative Modeling for Molecular Innovation
-Jeremy Edmunds
Executive Director Immunology Chemistry
AbbVie
Innovative and Emerging Modalities
From Molecules to Medicine: A Deep Dive into the Integration of Chemoinformatics and Big Data Analytics for Transformative Advances in Drug Discovery
Chemical Biology, Targeted Protein Degradation & Undruggables
Understanding Protein Degradation Pathways and Implications for Biologics Stability and Efficacy
-Monica Schenone
Head of Chemical Biology
Pfizer
Hit Identification / Lead Optimization
From Hits to Leads: Advanced Strategies and Technologies for Enhancing Drug Discovery in the Initial Phases
Design & Synthesis
Emerging Techniques in Peptide and Protein Synthesis
Integrated Drug Discovery
Emerging Modalities in Integrated Drug Discovery: Turning the Tide on Undruggable Proteins
Reasons To Attend the Strategy Meeting
Discussions on the advancements in targeted protein degradation andrnpushing past its boundaries.
Leveraging Artificial Intelligence and Machine Learning in accelerating therndevelopment of new drugs
Discuss approaches to further understand the interactions of undruggablerntargets and different Protein Degraders such as PROTACs, Molecular Glues,rnetc
Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more
Our 2024 Sponsors
Thought Leaders
Co-Host
Partnering Sponsor
Key Opinion Leaders
Our 2024 Media Partners
Press play to hear what your colleagues had to say...
Hotel & Venue
Le Méridien Boston Cambridge
Le Méridien Cambridge-MIT’s elegant guest rooms and suites offer a place of luxurious sanctuary and unmatched comfort. Explore unique programs inspired by the brand’s European heritage. Born in a glamorous era of travel, Le Méridien believes everyone should explore the world in style.
Hotel Details Maps & Direction Parking
Want to find out more?
Find out more details about our Strategy Meetings and other news and events.
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.
Payment Securely powered by stripe
